These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 184370)
41. Glycosylation of lipoproteins: chemistry and biological implications. Flückiger R Monogr Atheroscler; 1985; 13():53-62. PubMed ID: 3911059 [No Abstract] [Full Text] [Related]
42. Changes in the connective tissue of the atherosclerotic intima and media of the aorta. Anastassiades T; Anastassiadis A; Denstedt OF Biochim Biophys Acta; 1971 Feb; 261(2):418-27. PubMed ID: 4259342 [No Abstract] [Full Text] [Related]
43. Diabetes, lipoproteins, and atherosclerosis. Schonfeld G Metabolism; 1985 Dec; 34(12 Suppl 1):45-50. PubMed ID: 3906360 [TBL] [Abstract][Full Text] [Related]
44. Determinants of the atherogenic flux of low-density lipoprotein into arteries. Born GV; Shafi S; Cusack NJ Arzneimittelforschung; 1990 Mar; 40(3A):354-6. PubMed ID: 2185763 [TBL] [Abstract][Full Text] [Related]
45. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis. Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304 [TBL] [Abstract][Full Text] [Related]
46. Role of the arterial smooth muscle cell in the pathogenesis of atherosclerosis. Pietilä K; Nikkari T Med Biol; 1983 Feb; 61(1):31-44. PubMed ID: 6341723 [TBL] [Abstract][Full Text] [Related]
47. Low density lipoprotein interaction with artery derived proteoglycan: the influence of LDL particle size and the relationship to atherosclerosis susceptibility. Wagner WD; Edwards IJ; St Clair RW; Barakat H Atherosclerosis; 1989 Jan; 75(1):49-59. PubMed ID: 2930613 [TBL] [Abstract][Full Text] [Related]
48. [Histoautoradiographic and biochemical study of the transport of atherogenic lipoproteins in the vascular wall]. Popov AV; Ketlinskiĭ SA; Tararak EM Arkh Patol; 1975; 37(10):25-30. PubMed ID: 178292 [TBL] [Abstract][Full Text] [Related]
49. Oxidative modification of low density lipoprotein and its relation to atherosclerosis. Aviram M Isr J Med Sci; 1995 Apr; 31(4):241-9. PubMed ID: 7721566 [No Abstract] [Full Text] [Related]
50. Role of oxidized low density lipoprotein in atherogenesis. Witztum JL; Steinberg D J Clin Invest; 1991 Dec; 88(6):1785-92. PubMed ID: 1752940 [TBL] [Abstract][Full Text] [Related]
51. Modified low density lipoproteins in the pathogenesis of atherosclerosis. Laurman W Int J Occup Med Environ Health; 1994; 7(1):65-76. PubMed ID: 7921905 [TBL] [Abstract][Full Text] [Related]
52. [Low density lipoprotein (LDL) heterogeneity and atherosclerosis]. Dejager S; Cohen R; Bruckert E Ann Biol Clin (Paris); 1990; 48(3):154-60. PubMed ID: 2191608 [TBL] [Abstract][Full Text] [Related]
53. Connective tissue components of the normal and fibrotic liver. I. Structure, local distribution and metabolism of connective tissue components in the normal liver and changes in chronic liver diseases. Rauterberg J; Voss B; Pott G; Gerlach U Klin Wochenschr; 1981 Jul; 59(14):767-79. PubMed ID: 7021993 [TBL] [Abstract][Full Text] [Related]
55. Atherogenic, dense low-density lipoproteins. Pathophysiology and new therapeutic approaches. Chapman MJ; Guérin M; Bruckert E Eur Heart J; 1998 Feb; 19 Suppl A():A24-30. PubMed ID: 9519339 [TBL] [Abstract][Full Text] [Related]
56. Low density lipoprotein (LDL) modification: basic concepts and relationship to atherosclerosis. Sevanian A; Asatryan L; Ziouzenkova O Blood Purif; 1999; 17(2-3):66-78. PubMed ID: 10449864 [TBL] [Abstract][Full Text] [Related]
57. [Progress in the study of lipoprotein metabolism and atherosclerosis: lipoprotein metabolism of arterial wall cells and atherosclerosis]. Saito Y Nihon Rinsho; 1988 Mar; 46(3):629-35. PubMed ID: 3404689 [No Abstract] [Full Text] [Related]
58. Oxidation of lipoproteins and atherosclerosis. Luc G; Fruchart JC Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389 [TBL] [Abstract][Full Text] [Related]
59. On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety. Bhakdi S; Dorweiler B; Kirchmann R; Torzewski J; Weise E; Tranum-Jensen J; Walev I; Wieland E J Exp Med; 1995 Dec; 182(6):1959-71. PubMed ID: 7500042 [TBL] [Abstract][Full Text] [Related]
60. [Pulmonary fibrous ground substance. Macromolecules of the intercellular matrix]. Robert L Ann Anesthesiol Fr; 1980; 21(6):599-602. PubMed ID: 6111265 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]